Neuropathic pain (NP) is a highly invalidating disease resulting as consequence of a lesion or disease affecting the somatosensory system. All the pharmacological treatments today in use give a long lasting pain relief only in a limited percentage of patients before pain reappears making NP an incurable disease. New approaches are therefore needed and research is testing stem cell usage. Several papers have been written on experimental neuropathic pain treatment using stem cells of different origin and species to treat experimental NP. The original idea was based on the capacity of stem cell to offer a totipotent cellular source for replacing injured neural cells and for delivering trophic factors to lesion site; soon the researchers agreed that the capacity of stem cells to contrast NP was not dependent upon their regenerative effect but was mostly linked to a bidirectional interaction between the stem cell and damaged microenvironment resident cells. In this paper we review the preclinical studies produced in the last years assessing the effects induced by several stem cells in different models of neuropathic pain. The overall positive results obtained on pain remission by using stem cells that are safe, of easy isolation, and which may allow an autologous transplant in patients may be encouraging for moving from bench to bedside, although there are several issues that still need to be solved.

Adult stem cell as new advanced therapy for experimental neuropathic pain treatmen / S. Franchi, M. Castelli, G. Amodeo, S. Niada, D. Ferrari, A. Vescovi, A. Brini, A. Panerai, P. Sacerdote. - In: BIOMED RESEARCH INTERNATIONAL. - ISSN 2314-6141. - 2014(2014), pp. 470983.1-470983.10. [10.1155/2014/470983]

Adult stem cell as new advanced therapy for experimental neuropathic pain treatmen

S. Franchi
Primo
;
M. Castelli
Secondo
;
G. Amodeo;S. Niada;A. Brini;A. Panerai
Penultimo
;
P. Sacerdote
Ultimo
2014

Abstract

Neuropathic pain (NP) is a highly invalidating disease resulting as consequence of a lesion or disease affecting the somatosensory system. All the pharmacological treatments today in use give a long lasting pain relief only in a limited percentage of patients before pain reappears making NP an incurable disease. New approaches are therefore needed and research is testing stem cell usage. Several papers have been written on experimental neuropathic pain treatment using stem cells of different origin and species to treat experimental NP. The original idea was based on the capacity of stem cell to offer a totipotent cellular source for replacing injured neural cells and for delivering trophic factors to lesion site; soon the researchers agreed that the capacity of stem cells to contrast NP was not dependent upon their regenerative effect but was mostly linked to a bidirectional interaction between the stem cell and damaged microenvironment resident cells. In this paper we review the preclinical studies produced in the last years assessing the effects induced by several stem cells in different models of neuropathic pain. The overall positive results obtained on pain remission by using stem cells that are safe, of easy isolation, and which may allow an autologous transplant in patients may be encouraging for moving from bench to bedside, although there are several issues that still need to be solved.
spinal-cord-injury; sciatic-nerve constriction; embryonic human CNS; in-vitro; nociceptive hypersensitivity; peripheral neuropathy; transplantation; system; allodynia; mice
Settore BIO/14 - Farmacologia
2014
Article (author)
File in questo prodotto:
File Dimensione Formato  
2014 Review stem cell.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 1.27 MB
Formato Adobe PDF
1.27 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/258306
Citazioni
  • ???jsp.display-item.citation.pmc??? 18
  • Scopus 42
  • ???jsp.display-item.citation.isi??? 39
social impact